Call us Toll-Free
800-476-6070

Weitz & Luxenberg Facebook Weitz & Luxenberg Google Weitz & Luxenberg Twitter Weitz & Luxenberg LinkedIn
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
Were you diagnosed with lung cancer? Yes
Were you diagnosed with Mesothelioma? yes
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients: Immunotoxin Therapy Outcome Measures

Read about the outcome measures for a current clinical trial being conducted to study the effects of Immunotoxin Therapy for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the study is currently being conducted only in Zurich, Switzerland.

Primary Outcome Measures:
• Maximum tolerated dose of SS1(dsFv)-PE38 immunotoxin [ Designated as safety issue: Yes ]
• Pharmacokinetics of SS1(dsFv)-PE38 immunotoxin [ Designated as safety issue: No ]
• Antitumor response [ Designated as safety issue: No ]

Secondary Outcome Measures:
• Measurement of antibody formation to drug and impact on pharmacokinetics [ Designated as safety issue: No ]

Recruitment Information:
Recruitment Status: Recruiting
Enrollment: 24
Estimated Start Date: June 2007
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos
Real Stories


IN THIS SECTION
Immunotoxin therapy for mesothelioma patients
Objectives of Immunotoxin trial on mesothelioma
Study outline for Immunotoxin mesothelioma trial
Disease traits in Immunotoxin mesothelioma trial
Patient traits: Immunotoxin mesothelioma trial
Contact info for Immunotoxin mesothelioma program


RETURN BACK TO
Mesothelioma
Mesothelioma Treatments
Treatment
Clinical trials for mesothelioma

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

Mesothelioma Lawyer

Asbestos Lawyer

Mesothelioma Attorney

Asbestos Attorney

Mesothelioma Treatment

see also:

Study outline for Immunotoxin mesothelioma trial Study outline for program to treat mesothelioma with Immunotoxin
Study outline for identifying effects of Immunotoxin on mesothelioma

Objectives of Immunotoxin trial on mesothelioma Study objectives for program to treat mesothelioma with Immunotoxin
Primary objectives of Immunotoxin clinical trial against mesothelioma

Current Immunotoxin therapy: mesothelioma patients Current clinical trial of Immunotoxin therapy: mesothelioma patients
Immunotoxin may inhibit cancer cell growth in mesothelioma test